Compound profile · Recovery research

Semaglutide

The GLP-1 drug behind the weight-loss wave - sold as Ozempic and Wegovy. Apex doesn't supply it; this is here to inform.

Tissue research Janoshik verified
StatusResearch use only
BPC-157
BPC-157
Dhs. 349.00
Shop now
01

The one that started the wave.

Semaglutide is the GLP-1 medicine that turned weight-loss drugs into headlines. It mimics a gut hormone to curb appetite and steady blood sugar - a fully approved, prescription-only medication, included here so you understand it, not because Apex sells it.

01
Approved & prescription
Sold as Ozempic (diabetes) and Wegovy (weight loss); prescription-only.
02
Real trial data
Around 15% average body-weight loss at 68 weeks in the STEP trials.
03
Heart benefit
The SELECT trial showed reduced cardiovascular events.
Primary structure
GLP-1 receptor agonist
Long-acting GLP-1 analog
Calculate your reconstitution dosage →
03

At a glance

~15%
Weight loss (STEP)
Weekly
Dosing
Rx
Prescription
04

Where the research focuses.

01
Weight management

Approved for chronic weight management; ~15% average loss in trials.

02
Type 2 diabetes

Its original approved use - improving blood-sugar control.

03
Cardiovascular risk

Reduced major cardiac events in the SELECT trial.

04
Appetite regulation

Curbs appetite and slows gastric emptying.

05

A gut hormone, extended.

Semaglutide is a modified version of GLP-1, a hormone released after eating that signals fullness and helps regulate blood sugar. The modification lets one dose last about a week.

It is one of the most rigorously trialled drugs on this entire list and, crucially, an approved medicine, not a research compound.

06

Strength of the evidence.

Tier 01
Strongest support
  • Large phase-3 RCTs (STEP programme)
  • FDA approval for obesity and diabetes
  • Cardiovascular benefit (SELECT)
Tier 02
Moderate support
  • Liver and metabolic secondary benefits
  • Real-world effectiveness data
Tier 03
Emerging / unverified
  • Compounded 'research' versions (quality risk)
  • Very-long-term use questions
07

How it works

01
GLP-1 agonism

Activates GLP-1 receptors to signal fullness.

Established
02
Gastric emptying

Slows the stomach, prolonging satiety.

Established
03
Glucose control

Enhances insulin, lowers glucagon.

Clinical
04
Side effects

Nausea and GI effects common, usually dose-related.

Documented
08

Signs of a quality compound

Lyophilised cake or powder
A fine, fluffy white cake — not oily, clumped or discoloured.
Clear reconstitution
Dissolves to a clear, colourless solution with no visible particles or cloudiness.
Batch-specific COA
Independent HPLC purity and mass-spec identity for the exact lot — not a recycled generic PDF.
Intact seal & vacuum
Sealed flip-top vial under vacuum; correct fill; legible batch and storage marking.
Walk away if…
No COA, oily residue, off-colour, partial vacuum, or purity claims with no independent test behind them.
Suspiciously cheap
Pricing far below the market for a well-tested compound usually means skipped testing or underfilled vials.
Regulatory & status
Approved medicine - not an Apex product.

Semaglutide is a prescription medication (Ozempic / Wegovy), protected by patents. Apex does not sell it. Gray-market 'research' GLP-1s exist but carry quality, safety and legal risks; the only legitimate access is a prescription. This profile is for information.

Approval
FDA-approved (Ozempic / Wegovy)
Access
Prescription only
Apex
Not sold · education only
Watch
GI effects · patent-protected
Research handling
Important notices
  • For research purposes only
  • Not for human consumption
  • Not FDA approved
  • Consult a qualified professional
Important

For research use only. Not for human consumption. Apex Academy is an educational reference describing findings reported in published and preclinical literature. Nothing here is medical advice, a protocol, or a recommendation to administer any compound to humans or animals. Many compounds described are investigational and are not approved by the FDA or other regulators for the prevention, treatment, or cure of any condition. Their long-term safety and pharmacokinetics remain incompletely characterized. Dose ranges, where shown, describe quantities used in cited research models - not instructions for use. Consult a qualified, licensed professional before making any health decision.